DK1354884T3 - Cyklopenta[d]pyrazolo[1,5-a]pyrimidinforbindelse som CRF-receptorantagonist - Google Patents

Cyklopenta[d]pyrazolo[1,5-a]pyrimidinforbindelse som CRF-receptorantagonist

Info

Publication number: DK1354884T3
Authority: DK; Denmark
Prior art keywords: ring; cyclopenta; pyrazolo; nitrogen; receptor antagonist
Prior art date: 2000-12-28

Application number

DK01995808T

Other languages

Danish (da)

English (en)

Inventor

Hisao Nakai

Y Kagamiishi

Original Assignee

Ono Pharmaceutical Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-12-28

Filing date

2001-12-27

Publication date

2008-03-03

2001-12-27 Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co

2008-03-03 Application granted granted Critical

2008-03-03 Publication of DK1354884T3 publication Critical patent/DK1354884T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Immunology (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Addiction (AREA)
Endocrinology (AREA)
Pulmonology (AREA)
Obesity (AREA)
Hematology (AREA)
Hospice & Palliative Care (AREA)
Orthopedic Medicine & Surgery (AREA)
Urology & Nephrology (AREA)
Psychology (AREA)
Anesthesiology (AREA)
Emergency Medicine (AREA)
Ophthalmology & Optometry (AREA)
Child & Adolescent Psychology (AREA)
Vascular Medicine (AREA)

DK01995808T 2000-12-28 2001-12-27 Cyklopenta[d]pyrazolo[1,5-a]pyrimidinforbindelse som CRF-receptorantagonist DK1354884T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2000402517		2000-12-28
PCT/JP2001/011581 WO2002053565A1 (en)	2000-12-28	2001-12-27	Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient

Publications (1)

Publication Number	Publication Date
DK1354884T3 true DK1354884T3 (da)	2008-03-03

Family

ID=18866787

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK01995808T DK1354884T3 (da)	2000-12-28	2001-12-27	Cyklopenta[d]pyrazolo[1,5-a]pyrimidinforbindelse som CRF-receptorantagonist

Country Status (24)

Country	Link
US (3)	US7034153B2 (ja)
EP (2)	EP1832590B8 (ja)
JP (2)	JP3528968B2 (ja)
KR (1)	KR100843281B1 (ja)
CN (2)	CN1274690C (ja)
AT (2)	ATE375345T1 (ja)
AU (1)	AU2002226674B2 (ja)
BR (1)	BR0116609A (ja)
CA (1)	CA2432148C (ja)
CZ (1)	CZ20031777A3 (ja)
DE (1)	DE60130924T2 (ja)
DK (1)	DK1354884T3 (ja)
ES (2)	ES2294047T3 (ja)
HU (1)	HUP0303653A3 (ja)
IL (2)	IL156609A0 (ja)
MX (1)	MXPA03005913A (ja)
NO (1)	NO326522B1 (ja)
NZ (1)	NZ526712A (ja)
PL (1)	PL363381A1 (ja)
PT (1)	PT1354884E (ja)
RU (1)	RU2291869C2 (ja)
TW (1)	TWI293630B (ja)
WO (1)	WO2002053565A1 (ja)
ZA (1)	ZA200305003B (ja)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6562965B1 (en) *	2000-07-06	2003-05-13	Bristol-Myers Squibb Pharma Company	Convergent synthesis of α-aryl-β-ketonitriles
KR100843281B1 (ko) *	2000-12-28	2008-07-09	오노 야꾸힝 고교 가부시키가이샤	삼환식 복소환 유도체 화합물 및 그 화합물을 유효성분으로 하는 의약
UA80295C2 (en) *	2002-09-06	2007-09-10	Biogen Inc	Pyrazolopyridines and using the same
US7129239B2 (en)	2002-10-28	2006-10-31	Pfizer Inc.	Purine compounds and uses thereof
US7247628B2 (en)	2002-12-12	2007-07-24	Pfizer, Inc.	Cannabinoid receptor ligands and uses thereof
US7329658B2 (en)	2003-02-06	2008-02-12	Pfizer Inc	Cannabinoid receptor ligands and uses thereof
US7176210B2 (en) *	2003-02-10	2007-02-13	Pfizer Inc.	Cannabinoid receptor ligands and uses thereof
US7141669B2 (en)	2003-04-23	2006-11-28	Pfizer Inc.	Cannabiniod receptor ligands and uses thereof
US7145012B2 (en)	2003-04-23	2006-12-05	Pfizer Inc.	Cannabinoid receptor ligands and uses thereof
US7268133B2 (en)	2003-04-23	2007-09-11	Pfizer, Inc. Patent Department	Cannabinoid receptor ligands and uses thereof
US7232823B2 (en)	2003-06-09	2007-06-19	Pfizer, Inc.	Cannabinoid receptor ligands and uses thereof
EP1637521B1 (en) *	2003-06-23	2013-06-19	Ono Pharmaceutical Co., Ltd.	Novel tricyclic heterocycle compound
AU2004249629B2 (en) *	2003-06-25	2009-07-30	Ono Pharmaceutical Co., Ltd.	Methanesulfonic acid salt of pyrazolopyrimidine compound, crystal thereof, and process for producing the same
JPWO2005061508A1 (ja) *	2003-12-22	2007-07-12	小野薬品工業株式会社	三環式複素環化合物およびその化合物を有効成分とする医薬
WO2005087775A1 (ja) *	2004-03-15	2005-09-22	Ono Pharmaceutical Co., Ltd.	三環式複素環化合物およびその化合物を有効成分として含有する医薬組成物
EP1773345B1 (en) *	2004-06-30	2013-12-11	Athersys, Inc.	Non-imidazole tertiary amines as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other cns disorders
US7868037B2 (en)	2004-07-14	2011-01-11	Ptc Therapeutics, Inc.	Methods for treating hepatitis C
EA200700243A1 (ru)	2004-07-14	2007-08-31	ПиТиСи ТЕРАПЬЮТИКС, ИНК.	Способы лечения гепатита с
CA2578636A1 (en)	2004-07-22	2006-02-23	Ptc Therapeutics, Inc.	Thienopyridines for treating hepatitis c
AR051780A1 (es) *	2004-11-29	2007-02-07	Japan Tobacco Inc	Compuestos en anillo fusionados que contienen nitrogeno y utilizacion de los mismos
EP1829874B1 (en)	2004-12-22	2014-02-12	Ono Pharmaceutical Co., Ltd.	Tricyclic compound and use thereof
TW200639163A (en)	2005-02-04	2006-11-16	Genentech Inc	RAF inhibitor compounds and methods
WO2009093747A1 (en) *	2008-01-22	2009-07-30	Takeda Pharmaceutical Company Limited	Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharmaceutical compositions containing them
US8309559B2 (en)	2008-01-24	2012-11-13	Nikolay Filippovich Savchuk	(EN) substituted 2-amino-3-sulfonyl-pyrazolo[1,5-A] pyrimidines/antagonists of serotonin 5-HT6 receptors, methods for the production and the use thereof
RU2369600C1 (ru) *	2008-01-24	2009-10-10	Андрей Александрович Иващенко	ЗАМЕЩЕННЫЕ 4-СУЛЬФОНИЛ-ПИРАЗОЛЫ И 3-СУЛЬФОНИЛ-ПИРАЗОЛО[1,5-a]ПИРИМИДИНЫ - АНТАГОНИСТЫ СЕРОТОНИНОВЫХ5-HT6 РЕЦЕПТОРОВ, АКТИВНЫЙ КОМПОНЕНТ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ЛЕКАРСТВЕННОЕ СРЕДСТВО И СПОСОБЫ ИХ ПОЛУЧЕНИЯ
RU2376291C1 (ru) *	2008-05-07	2009-12-20	Андрей Александрович Иващенко	ЗАМЕЩЕННЫЕ 3,5-ДИАМИНО-4-СУЛЬФОНИЛ-ПИРАЗОЛЫ И 2-АМИНО-3-СУЛЬФОНИЛ-ПИРАЗОЛО[1,5-a]ПИРИМИДИНЫ - АНТАГОНИСТЫ СЕРОТОНИНОВЫХ 5-HT6 РЕЦЕПТОРОВ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ
KR20130043207A (ko) *	2010-07-22	2013-04-29	자프겐 인크.	트리시클릭 화합물 및 이의 제조 및 사용 방법
WO2012047570A1 (en) *	2010-09-28	2012-04-12	Schering Corporation	Fused tricyclic inhibitors of mammalian target of rapamycin
WO2012047569A1 (en) *	2010-09-28	2012-04-12	Schering Corporation	Fused tricyclic inhibitors of mammalian target of rapamycin
HUE038046T2 (hu) *	2010-12-17	2018-09-28	Reata Pharmaceuticals Inc	Antioxidáns gyulladáscsökkentõ pirazolil és pirimidinil triciklusos enonok
EP2760453B1 (en)	2011-09-30	2016-05-25	Ipsen Pharma S.A.S.	Macrocyclic lrrk2 kinase inhibitors
TR201904514T4 (tr)	2014-09-17	2019-04-22	Oncodesign Sa	Makrosiklik LRRK2 kinaz inhibitörleri.
US11220510B2 (en)	2018-04-09	2022-01-11	Incyte Corporation	Pyrrole tricyclic compounds as A2A / A2B inhibitors
CA3163735A1 (en) *	2019-12-03	2021-06-10	Turning Point Therapeutics, Inc.	Macrocycles for use in treating disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR927003595A (ko)	1990-10-09	1992-12-18	오츠카 아키히코	피리미딘 유도체, 이의 제조방법 및 안드로겐 저해제
CN1169149A (zh)	1995-09-28	1997-12-31	株式会社大制药工场	止痛组合物
CA2263566C (en)	1996-08-28	2003-09-09	Pfizer Inc.	Substituted 6,5-hetero-bicyclic derivatives
AU4556999A (en) *	1998-06-09	1999-12-30	Neurogen Corporation	Pyrido[2,3-b]indolizine derivatives and aza analogues thereof; crf1 specific ligands
ATE240958T1 (de) *	1998-11-12	2003-06-15	Neurocrine Biosciences Inc	Crf rezeptor-antagonisten und darauf bezogene methoden
EP1129091B1 (en) *	1998-11-12	2002-10-02	Neurocrine Biosciences, Inc.	Crf receptor antagonists and methods relating thereto
KR100843281B1 (ko) *	2000-12-28	2008-07-09	오노 야꾸힝 고교 가부시키가이샤	삼환식 복소환 유도체 화합물 및 그 화합물을 유효성분으로 하는 의약

2001
- 2001-12-27 KR KR1020037008815A patent/KR100843281B1/ko not_active Expired - Fee Related
- 2001-12-27 CN CNB018227201A patent/CN1274690C/zh not_active Expired - Fee Related
- 2001-12-27 AT AT01995808T patent/ATE375345T1/de active
- 2001-12-27 CA CA2432148A patent/CA2432148C/en not_active Expired - Fee Related
- 2001-12-27 NZ NZ526712A patent/NZ526712A/en unknown
- 2001-12-27 WO PCT/JP2001/011581 patent/WO2002053565A1/ja not_active Ceased
- 2001-12-27 EP EP07111569A patent/EP1832590B8/en not_active Expired - Lifetime
- 2001-12-27 IL IL15660901A patent/IL156609A0/xx unknown
- 2001-12-27 HU HU0303653A patent/HUP0303653A3/hu unknown
- 2001-12-27 AT AT07111569T patent/ATE526330T1/de not_active IP Right Cessation
- 2001-12-27 ES ES01995808T patent/ES2294047T3/es not_active Expired - Lifetime
- 2001-12-27 JP JP2002555088A patent/JP3528968B2/ja not_active Expired - Fee Related
- 2001-12-27 US US10/250,328 patent/US7034153B2/en not_active Expired - Fee Related
- 2001-12-27 ES ES07111569T patent/ES2369837T3/es not_active Expired - Lifetime
- 2001-12-27 CZ CZ20031777A patent/CZ20031777A3/cs unknown
- 2001-12-27 MX MXPA03005913A patent/MXPA03005913A/es active IP Right Grant
- 2001-12-27 PT PT01995808T patent/PT1354884E/pt unknown
- 2001-12-27 RU RU2003119138/04A patent/RU2291869C2/ru not_active IP Right Cessation
- 2001-12-27 CN CNA2006101061544A patent/CN1896076A/zh active Pending
- 2001-12-27 BR BR0116609-3A patent/BR0116609A/pt not_active Application Discontinuation
- 2001-12-27 PL PL01363381A patent/PL363381A1/xx unknown
- 2001-12-27 AU AU2002226674A patent/AU2002226674B2/en not_active Ceased
- 2001-12-27 DE DE60130924T patent/DE60130924T2/de not_active Expired - Lifetime
- 2001-12-27 EP EP01995808A patent/EP1354884B1/en not_active Expired - Lifetime
- 2001-12-27 DK DK01995808T patent/DK1354884T3/da active
- 2001-12-28 TW TW090132698A patent/TWI293630B/zh not_active IP Right Cessation
2003
- 2003-06-24 IL IL156609A patent/IL156609A/en not_active IP Right Cessation
- 2003-06-26 NO NO20032956A patent/NO326522B1/no not_active IP Right Cessation
- 2003-06-26 ZA ZA2003/05003A patent/ZA200305003B/en unknown
- 2003-12-05 JP JP2003406938A patent/JP4217968B2/ja not_active Expired - Fee Related
2005
- 2005-09-07 US US11/219,736 patent/US7459459B2/en not_active Expired - Fee Related
2008
- 2008-09-02 US US12/202,984 patent/US7807688B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US20060122392A1 (en)	2006-06-08
BR0116609A (pt)	2005-02-15
CA2432148C (en)	2011-01-18
US7034153B2 (en)	2006-04-25
NO326522B1 (no)	2008-12-22
CN1896076A (zh)	2007-01-17
ES2369837T3 (es)	2011-12-07
EP1832590B1 (en)	2011-09-28
EP1832590A3 (en)	2007-11-14
US20090137604A1 (en)	2009-05-28
ATE375345T1 (de)	2007-10-15
EP1832590A2 (en)	2007-09-12
DE60130924D1 (de)	2007-11-22
CZ20031777A3 (cs)	2003-10-15
AU2002226674B2 (en)	2007-03-22
CA2432148A1 (en)	2002-07-11
JP3528968B2 (ja)	2004-05-24
ES2294047T3 (es)	2008-04-01
JP2004083597A (ja)	2004-03-18
EP1354884A1 (en)	2003-10-22
US20040072833A1 (en)	2004-04-15
IL156609A0 (en)	2004-01-04
CN1274690C (zh)	2006-09-13
NO20032956L (no)	2003-08-28
KR20030070593A (ko)	2003-08-30
HUP0303653A2 (hu)	2004-03-01
DE60130924T2 (de)	2008-07-17
ZA200305003B (en)	2005-07-27
RU2291869C2 (ru)	2007-01-20
US7459459B2 (en)	2008-12-02
ATE526330T1 (de)	2011-10-15
NZ526712A (en)	2005-03-24
EP1832590B8 (en)	2012-04-25
US7807688B2 (en)	2010-10-05
JPWO2002053565A1 (ja)	2004-05-13
PL363381A1 (en)	2004-11-15
WO2002053565A1 (en)	2002-07-11
PT1354884E (pt)	2007-12-24
JP4217968B2 (ja)	2009-02-04
HUP0303653A3 (en)	2006-05-29
NO20032956D0 (no)	2003-06-26
KR100843281B1 (ko)	2008-07-09
CN1491225A (zh)	2004-04-21
MXPA03005913A (es)	2005-04-19
IL156609A (en)	2010-02-17
EP1354884B1 (en)	2007-10-10
TWI293630B (en)	2008-02-21
EP1354884A4 (en)	2005-09-07

Publication	Publication Date	Title
DK1354884T3 (da)	2008-03-03	Cyklopenta[d]pyrazolo[1,5-a]pyrimidinforbindelse som CRF-receptorantagonist
ES2125294T3 (es)	1999-03-01	Imidazo(1,2-a)piridinas como antagonistas de la bradiquinina.
HUP0202795A2 (hu)	2003-02-28	Pirimidin- és pirazinszármazékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
CA2523261A1 (en)	2004-11-18	Fused pyrimidine derivatives with crf activity
SE9701398D0 (sv)	1997-04-15	Novel compounds
EA200400236A1 (ru)	2004-10-28	Производные замещенного 2-пиримидинил-6,7,8,9-тетрагидропиримидо[1,2-a]пиримидин-4-она и 7-пиримидинил-2,3-дигидроимидазо[1,2-a]пиримидин-5(1h)она для нейродегенеративных нарушений
WO2001027111A3 (de)	2001-06-14	Bicyclische imidazo-3-yl-aminderivate
EP1939175A4 (en)	2009-07-22	SULFONAMIDE DERIVATIVITY WITH PGD2 RECEPTOR ANTAGONISTIC EFFECT
CA2197298A1 (en)	1996-02-22	Novel Pyrimidine Derivatives and Processes for the Preparation Thereof
BR0114584A (pt)	2003-08-26	Monohidrato cristalino, processos para a sua preparação e sua aplicação para a preparação de um medicamento
IL111959A (en)	2000-07-16	N-(polysubstituted pyrimidin-4-yl) benzenesulfonamide derivatives their preparation and pharmaceutical compositions containing them
NO20023974D0 (no)	2002-08-21	Ny krystallinsk form av N-[4-[2-(2-amino-4,7-dihydro-4-okso- 3H-pyrrolo[2,3-d]pyrimidin-5-yl)etyl]benzoyl]-L-glutaminsyre ogfremgangsmåte for fremstilling derav
NO175259C (no)	1994-09-21	Analogifremgangsmåte for fremstilling av terapeutisk aktive triazolo-1,4-diazepinforbindelser
SE0102036D0 (sv)	2001-06-08	Pharmaceutical formulation for the efficient administration of apomorphine, 6aR- (-) -N- Propyl- norapomorphine and their derivatives and pro-drugs thereof
CL2003002050A1 (es)	2005-01-07	Compuestos derivados de 1-piperazin-1,2-dihidroindeno, su composicion farmaceutica y el uso de esta para tratar enfermedades del sistema nervioso central.
TR200402342T4 (tr)	2004-11-22	2-Pirindinil-6,7,8,9- Tetrahidropyrimido[1,2-A] Pirimidin-4-On ve 7-Pirindinil-1,3-Dihydoimidazo[1,2-A]Pirimidin-5(1H) on Türevleri
KR890014522A (ko)	1989-10-24	사이클릭 이미드의 아릴피페라지닐알콕시 유도체, 이의 제조방법 및 약제로서의 이의 용도
BR0211938A (pt)	2004-09-21	Composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, uso do dito composto ou de um sal ou solvato farmaceuticamente aceitável do mesmo, e, método para tratar os distúrbios de fertilidade em pacientes em necessidade do mesmo
ES2111352T3 (es)	1998-03-01	Uso de diester fosfato para el tratamiento de enfermedades retinianas.
EP1241170A3 (en)	2003-03-12	Pyrazolopyrimidine derivatives
EP1537879A4 (en)	2007-08-15	MEANS FOR THE PREVENTION AND / OR TREATMENT OF ASTHMA
HUP0004663A2 (hu)	2001-05-28	Szubsztituált izokinolinszármazékok, eljárás előállításukra és alkalmazásuk antikonvulzáns hatású gyógyszerkészítmények előállítására, valamint a vegyületeket tartalmazó gyógyszerkészítmények
ID30435A (id)	2001-12-06	Proses-proses untuk menyiapkan perantara-perantara pestisidal
ATE294780T1 (de)	2005-05-15	Arylpiperidin- und aryl-1,2,5,6- tetrahydropyridinamid-derivate mit 5ht1a rezeptor aktivität
NZ504124A (en)	2002-10-25	Phenyl-alkyl-imidazoles and use in treating inflammatory disease